Skip to main content

Rsv Vaccine, Pref A-Pref B, Recombinant Dosage

Medically reviewed by Drugs.com. Last updated on Aug 29, 2023.

Applies to the following strengths: preservative-free 60 mcg-60 mcg

Usual Adult Dose for Respiratory Syncytial Virus

Pregnant individuals between 32 and 36 weeks of gestation:
0.5 mL intramuscularly as a single dose.

Use: Active immunization for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth to 6 months of age

Usual Geriatric Dose for Respiratory Syncytial Virus

0.5 mL intramuscularly as a single dose.

Use: For active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS: History of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine.

Safety and efficacy have not been established in patients younger than 60 years, except pregnant individuals at 32 to 36 weeks gestational age.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

General:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.